Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.